全文获取类型
收费全文 | 2443篇 |
免费 | 207篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 58篇 |
妇产科学 | 34篇 |
基础医学 | 466篇 |
口腔科学 | 32篇 |
临床医学 | 289篇 |
内科学 | 564篇 |
皮肤病学 | 67篇 |
神经病学 | 242篇 |
特种医学 | 68篇 |
外科学 | 258篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 134篇 |
眼科学 | 28篇 |
药学 | 161篇 |
中国医学 | 5篇 |
肿瘤学 | 241篇 |
出版年
2023年 | 28篇 |
2022年 | 34篇 |
2021年 | 97篇 |
2020年 | 55篇 |
2019年 | 92篇 |
2018年 | 99篇 |
2017年 | 62篇 |
2016年 | 74篇 |
2015年 | 73篇 |
2014年 | 128篇 |
2013年 | 135篇 |
2012年 | 245篇 |
2011年 | 238篇 |
2010年 | 137篇 |
2009年 | 113篇 |
2008年 | 162篇 |
2007年 | 179篇 |
2006年 | 168篇 |
2005年 | 147篇 |
2004年 | 136篇 |
2003年 | 98篇 |
2002年 | 75篇 |
2001年 | 4篇 |
2000年 | 3篇 |
1999年 | 7篇 |
1998年 | 26篇 |
1997年 | 6篇 |
1996年 | 4篇 |
1995年 | 4篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1972年 | 2篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1969年 | 2篇 |
1967年 | 2篇 |
1966年 | 1篇 |
1964年 | 2篇 |
1963年 | 1篇 |
1960年 | 1篇 |
1911年 | 1篇 |
排序方式: 共有2657条查询结果,搜索用时 31 毫秒
111.
Increased extracellular matrix density decreases MCF10A breast cell acinus formation in 3D culture conditions
下载免费PDF全文
![点击此处可从《Journal of tissue engineering and regenerative medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Amanda Lance Chih‐Chao Yang Muthulekha Swamydas Delphine Dean Sandy Deitch Karen J. L. Burg Didier Dréau 《Journal of tissue engineering and regenerative medicine》2016,10(1):71-80
The extracellular matrix (ECM) contributes to the generation and dynamic of normal breast tissue, in particular to the generation of polarized acinar and ductal structures. In vitro 3D culture conditions, including variations in the composition of the ECM, have been shown to directly influence the formation and organization of acinus‐like and duct‐like structures. Furthermore, the density of the ECM appears to also play a role in the normal mammary tissue and tumour formation. Here we show that the density of the ECM directly influences the number, organization and function of breast acini. Briefly, non‐malignant human breast MCF10A cells were incubated in increasing densities of a Matrigel®–collagen I matrix. Elastic moduli near and distant to the acinus structures were measured by atomic force microscopy, and the number of acinus structures was determined. Immunochemistry was used to investigate the expression levels of E‐cadherin, laminin, matrix metalloproteinase‐14 and ß‐casein in MCF10A cells. The modulus of the ECM was significantly increased near the acinus structures and the number of acinus structures decreased with the increase in Matrigel–collagen I density. As evaluated by the expression of laminin, the organization of the acinus structures present was altered as the density of the ECM increased. Increases in both E‐cadherin and MMP14 expression by MCF10A cells as ECM density increased were also observed. In contrast, MCF10A cells expressed lower ß‐casein levels as the ECM density increased. Taken together, these observations highlight the key role of ECM density in modulating the number, organization and function of breast acini. Copyright © 2013 John Wiley & Sons, Ltd. 相似文献
112.
Flavien Rouxel Raissa Relator Jennifer Kerkhof Haley McConkey Michael Levy Patricia Dias Mouna Barat-Houari Nathalie Bednarek Odile Boute Nicolas Chatron Florian Cherik Andrée Delahaye-Duriez Martine Doco-Fenzy Laurence Faivre Lucas W. Gauthier Delphine Heron Michael S. Hildebrand Gaëtan Lesca David Genevieve 《Genetics in medicine》2022,24(5):1096-1107
PurposeRare genetic variants in CDK13 are responsible for CDK13-related disorder (CDK13-RD), with main clinical features being developmental delay or intellectual disability, facial features, behavioral problems, congenital heart defect, and seizures. In this paper, we report 18 novel individuals with CDK13-RD and provide characterization of genome-wide DNA methylation.MethodsWe obtained clinical phenotype and neuropsychological data for 18 and 10 individuals, respectively, and compared this series with the literature. We also compared peripheral blood DNA methylation profiles in individuals with CDK13-RD, controls, and other neurodevelopmental disorders episignatures. Finally, we developed a support vector machine–based classifier distinguishing CDK13-RD and non–CDK13-RD samples.ResultsWe reported health and developmental parameters, clinical data, and neuropsychological profile of individuals with CDK13-RD. Genome-wide differential methylation analysis revealed a global hypomethylated profile in individuals with CDK13-RD in a highly sensitive and specific model that could aid in reclassifying variants of uncertain significance.ConclusionWe describe the novel features such as anxiety disorder, cryptorchidism, and disrupted sleep in CDK13-RD. We define a CDK13-RD DNA methylation episignature as a diagnostic tool and a defining functional feature of the evolving clinical presentation of this disorder. We also show overlap of the CDK13 DNA methylation profile in an individual with a functionally and clinically related CCNK-related disorder. 相似文献
113.
Caroline Duault Delphine Betous Christine Bezombes Stéphane Roga Corinne Cayrol Jean‐Philippe Girard Jean‐Jacques Fournié Mary Poupot 《European journal of immunology》2017,47(12):2137-2141
From several years, the anticancer effects of Vγ9 T lymphocytes make these cells good candidates for cancer immunotherapies. However, the proved efficacy of γδ Τ cell‐based cancer immunotherapies in some clinical trials was minimized due to the inherent toxicity of IL‐2, which is essential for the combination therapy with Phosphoantigen (PAg). Recently, we showed that IL‐33, a γ chain receptor‐independent cytokine, was able to induce the in vitro proliferation of PAg‐activated Vγ9 T cells, which were fully functional expressing IFN‐γ and TNF‐α and showing in vitro anti‐tumor cytotoxicity. We proposed IL‐33 as an alternative to IL‐2 for Vγ9 T cell‐based cancer immunotherapies, and have therefore evaluated the efficacy of this cytokine in preclinical investigations. This study shows that human Vγ9 T cells are able to proliferate in a mouse model with the combination of PAg and rhIL‐33, and that IL‐33‐expanded Vγ9 T cells can prevent tumor growth in a mouse lymphoma model. 相似文献
114.
115.
Delphine Kerebel Luc-Marie Joly Didier Honnart Jeannot Schmidt Damien Galanaud Claude Negrier Friedrich Kursten Pierre Coriat Lex Investigator Group 《Critical care (London, England)》2013,17(1):R4
Introduction
Prothrombin complex concentrates (PCC) are haemostatic blood preparations indicated for urgent anticoagulation reversal, though the optimal dose for effective reversal is still under debate. The latest generation of PCCs include four coagulation factors, the so-called 4-factor PCC. The aim of this study was to compare the efficacy and safety of two doses, 25 and 40 IU/kg, of 4-factor PCC in vitamin K antagonist (VKA) associated intracranial haemorrhage.Methods
We performed a phase III, prospective, randomised, open-label study including patients with objectively diagnosed VKA-associated intracranial haemorrhage between November 2008 and April 2011 in 22 centres in France. Patients were randomised to receive 25 or 40 IU/kg of 4-factor PCC. The primary endpoint was the international normalised ratio (INR) 10 minutes after the end of 4-factor PCC infusion. Secondary endpoints were changes in coagulation factors, global clinical outcomes and incidence of adverse events (AEs).Results
A total of 59 patients were randomised: 29 in the 25 IU/kg and 30 in the 40 IU/kg group. Baseline demographics and clinical characteristics were comparable between the groups. The mean INR was significantly reduced to 1.2 - and ≤1.5 in all patients of both groups - 10 minutes after 4-factor PCC infusion. The INR in the 40 IU/kg group was significantly lower than in the 25 IU/kg group 10 minutes (P = 0.001), 1 hour (P = 0.001) and 3 hours (P = 0.02) after infusion. The 40 IU/kg dose was also effective in replacing coagulation factors such as PT (P = 0.038), FII (P = 0.001), FX (P <0.001), protein C (P = 0.002) and protein S (0.043), 10 minutes after infusion. However, no differences were found in haematoma volume or global clinical outcomes between the groups. Incidence of death and thrombotic events was similar between the groups.Conclusions
Rapid infusion of both doses of 4-factor PCC achieved an INR of 1.5 or less in all patients with a lower INR observed in the 40 IU/kg group. No safety concerns were raised by the 40 IU/kg dose. Further trials are needed to evaluate the impact of the high dose of 4-factor PCC on functional outcomes and mortality.Trial registration
Eudra CT number 2007-000602-73. 相似文献116.
117.
118.
Pulmonary endothelium as a site of synthesis and storage of interleukin-6 in experimental congestive heart failure 总被引:3,自引:0,他引:3
Gaertner R Lepailleur-Enouf D Gonzalez W Nicoletti A Mandet C Philippe M Mercadier JJ Michel JB 《European journal of heart failure》2003,5(4):435-442
BACKGROUND: Pulmonary endothelium is an early upstream hemodynamic target of left ventricular dysfunction. Interleukin 6 (IL-6) is a pro-inflammatory cytokine reported to increase in congestive heart failure (CHF) patients. AIMS: We sought to determine the origin of IL-6, IL-6 receptor (IL-6R) and gp130 in experimental CHF. METHODS: We used rats with coronary artery ligation as an experimental model of either compensated or decompensated heart failure. Lung and aorta samples were analysed by RT-PCR, ELISA and immunohistochemistry for IL-6 and its receptors. RESULTS: IL-6 mRNA expression increased in the lung of rats with decompensated heart failure and was positively correlated with infarct severity whereas IL-6R mRNA decreased in the lung of myocardial infarction rats and gp130 mRNA remained unchanged. In contrast, there were no changes in IL-6 mRNA expression in the aorta and left ventricular myocardium. IL-6 peptide content as determined by ELISA and Western Blot in lung tissue was 2-fold higher in decompensated heart failure as compared to control rats. These data were confirmed by immunohistochemistry showing a preferential endothelial localization of IL-6 in the CHF lung. IL-6 peptide was also present in the pleural effusion of decompensated heart failure and was positively correlated with IL-6 mRNA expression in the lungs of decompensated HF rats. Pulmonary IL-6 overexpression was associated with nuclear translocation of NF-kappaB and cytosolic degradation of IkappaB. CONCLUSION: Dysfunctional pulmonary endothelium is a source of synthesis and storage of IL-6 in an experimental model of CHF. 相似文献
119.
120.
Mouna Barat-Houari Karine Nguyen Rafa?lle Bernard C��line Fernandez Catherine Vovan Corinne Bareil Philippe Khau Van Kien Delphine Thorel Sylvie Tuffery-Giraud Francis Vasseur Shahram Attarian Jean Pouget Anne Girardet Nicolas L��vy Mireille Claustres 《European journal of human genetics : EJHG》2010,18(5):533-538